Yuhang Zhao, Ph.D.

Dr. Zhao holds a Ph.D. in Molecular Biology from Rockefeller University and an MBA in Finance from NYU Stern Business School. She has extensive experience and knowledge in new product development, registration, and commercialization of both drugs and medical devices. Prior to 2017, Dr. Zhao was a member of Bayer Global Leadership circle and established one of Bayer Pharmaceutical’s four Global Clinical Development sites in Beijing, China, and built the Global Strategy function for Consumer Health. Prior to Bayer, she had an unusual career that spanned academia, Wall Street, and management consulting. She was one of the earlier scientist-turned-biotech stock analysts on Wall Street (PaineWebber) in the 1990s and then a management consultant at Deloitte, specializing in R&D and new product launch strategies for life science companies. She currently serves on several biotech companies’ boards and is a senior advisor to CGE Holding.